A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)
Clinical trial NCT00943761 · COMPLETED
Trial details
- NCT number
- NCT00943761
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-23
- Primary completion
- 2013-05-29
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.